ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ELYM Eliem Therapeutics Inc

5.11
0.00 (0.00%)
20 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -8.75M-9.55M-23.44M-6.71M-5M-5.12M-3.01M-56.37M
Pre Tax Income -9.68M-7.76M-22.29M-5.22M-3.97M-3.64M-1.7M-54.89M
Net Income -9.68M-7.76M-22.29M-5.22M-3.97M-3.64M-1.7M-54.89M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.37M-9.55M-23.44M-6.71M-1.73M-5.12M-3.01M-53.55M
EBITDA -8.75M-9.55M-23.44M-6.71M-5M-5.12M-3.01M-56.37M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -35.67M-45.14M-40.28M
Pre Tax Income -47.48M-45.24M-35.12M
Net Income -52.03M-45.24M-35.12M
Preferred Dividends -4.55M00
Basic Earnings Per Share (EPS) -1.983-1.703-1.279
EBIT -47.31M-45.14M-40.28M
EBITDA -35.67M-45.14M-40.28M